Rossi Cedric

Rossi Cedric

Hématologie

Hôpital François Mitterrand
Dijon, France

171 Activités

392 Followers

Scientifique

Digital

Production scientifique

Activités par an

Expertise

Sujets de recherche

Lymphomes Maladie de Hodgkin Lymphome folliculaire Lymphome B Lymphome malin non hodgkinien Lymphome B diffus à grandes cellules Tumeurs hématologiques Myélome multiple Lymphome à cellules du manteau

Collaborateurs

Voir plus

Casasnovas Rene-Olivier

Hôpital François Mitterrand, Dijon, France

Ghesquieres Herve

Hôpital Lyon Sud, Pierre-Bénite, France

Laurent Camille

Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

Chauchet Adrien

Hôpital Jean-Minjoz, Besançon, France

Industries

Voir plus

Janssen

25 collaboration(s)

Dernière en 2023

CanceroDigest

18 collaboration(s)

Dernière en 2023

Takeda Pharmaceutical

9 collaboration(s)

Dernière en 2022

Edimark

8 collaboration(s)

Dernière en 2021

Dernières activités

Voir plus

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.

Nature 11 décembre 2023

Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries

65th ASH Annual Meeting Abstracts 02 novembre 2023

Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma

65th ASH Annual Meeting Abstracts 02 novembre 2023

Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults

65th ASH Annual Meeting Abstracts 02 novembre 2023

High IL1-RA Plasma Levels at Baseline Allow to Identify Hodgkin Lymphoma Patients with High Risk of Treatment Failure

65th ASH Annual Meeting Abstracts 02 novembre 2023

Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification

65th ASH Annual Meeting Abstracts 02 novembre 2023

Synthetic Control Arm from Clinical Trials and Real-World Data from Lysa Group for Untreated Diffuse Large B Cell Lymphoma Patients Aged over 80 Years: A Bona Fide Strategy for Innovative Clinical Trials

65th ASH Annual Meeting Abstracts 02 novembre 2023

Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods

65th ASH Annual Meeting Abstracts 02 novembre 2023

First Line Therapy Evaluation Using Propensity Score Approach in Newly Diagnosed Advanced Classical Hodgkin Lymphoma Patients from Prospective Real-World Realysa Cohort and Phase 3 AHL2011 Trial

65th ASH Annual Meeting Abstracts 02 novembre 2023

CD20low/CD68high a Promising Microenvironnement Profile Identifying Classical Hodgkin Lymphoma Patients with Poor Outcome a Lysa Study

65th ASH Annual Meeting Abstracts 02 novembre 2023